The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
Sign Up to like & getrecommendations! Published in 2022 at "RMD Open"
DOI: 10.1136/rmdopen-2022-002478
Abstract: Objective Post hoc analysis of pooled data from nine randomised controlled trials to assess the effect of tofacitinib (oral Janus kinase inhibitor for treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA)) on residual pain… read more here.
Keywords: tofacitinib adalimumab; patients psa; residual pain; arthritis ... See more keywords